An innovative care delivery model at Mayo Clinic integrates virtual oversight, remote patient monitoring, mobile health ...
Among adults with chronic rhinosinusitis with nasal polyps, those receiving verekitug vs. placebo at baseline and week 12 had significantly decreased nasal polyp size at week 24, according to a poster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results